Search Orphan Drug Designations and Approvals
-
| Generic Name: | Trans-Cinnamic Acid |
|---|---|
| Date Designated: | 11/24/2020 |
| Orphan Designation: | Treatment of GM2 gangliosidosis |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Polaryx Therapeutics, Inc. 140 E. Ridgewood Avenue, Suite 415, South Tower Paramus, New Jersey 07652 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
